Table 3.
Profiles of A. baumannii isolates used in western blotting and analyses of microbiologic characteristics.
| MIC (μg/mL) of antimicrobial agents b |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strain | Genotype | Date of isolation | Site of Infectiona | IMI | CAZ | A/S | P/T | GEN | CIP | SXT | COL | TGC |
| T6SS+ (active hcp+) | ||||||||||||
| B849 | ST357 | 2013 SEP 3 | SSTI | >64 | >64 | 64/32 | <256/4 | >64 | >64 | >32/608 | 2 | 1 |
| B1144 | ST357 | 2014 JUL 2 | CRBSI | >64 | >64 | 64/32 | <256/4 | >64 | >64 | >32/608 | 1 | 1 |
| 14AC-06 | ST208 | 2014 JAN 9 | VAP | >64 | >64 | >64/32 | <256/4 | >64 | 64 | >32/608 | 1 | 1 |
| T6SS– (inactive hcp+) | ||||||||||||
| B876 | ST357 | 2013 SEP 14 | CRBSI | 64 | >64 | >64/32 | <256/4 | 2 | >64 | >32/608 | 2 | 4 |
| 13AC-06 | ST369 | 2013 MAR 3 | CRBSI | >64 | >64 | 64/32 | <256/4 | >64 | 64 | >32/608 | 1 | 1 |
| T6SS– (hcp–) | ||||||||||||
| AC12 | ST191 | 2013 MAY 14 | IAI | >64 | >64 | >64/32 | <256/4 | 8 | >64 | >32/608 | 1 | 2 |
| B764 | ST191 | 2013 JUL 25 | IAI | >64 | >64 | >64/32 | <256/4 | >64 | >64 | >32/608 | 1 | 4 |
| 13AC-45 | ST369 | 2013 SEP 22 | Primary bacteremia | >64 | >64 | >64/32 | <256/4 | >64 | >64 | >32/608 | 1 | 1 |
Notes.
a
SSTI, skin and soft tissue infection; CRBSI, catheter-related bloodstream infection; VAP, ventilator-associated pneumonia; IAI, intra-abdominal infection
b
MIC, minimum inhibitory concentration; IMI, imipenem; CAZ, ceftazidime; A/S, ampicillin-sulbactam; P/T, piperacillin-tazobactam; GEN, gentamicin; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; COL, colistin; TGC, tigecycline